This inventor holds 1 USPTO granted patent. Top assignee: Dupont Pharmaceuticals Company. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Jay Andrew Markwalder: Innovator in HIV Research
Introduction
Jay Andrew Markwalder is a notable inventor based in Lincoln University, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target viral infections.
Latest Patents
Markwalder holds a patent for 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones, which are useful as inhibitors of HIV reverse transcriptase. This invention relates to benzoxazinones of a specific formula, including stereoisomeric forms or mixtures, and pharmaceutically acceptable salt forms. These compounds are designed to be effective in treating viral infections and are also applicable in pharmaceutical compositions and diagnostic kits.
Career Highlights
Markwalder is associated with DuPont Pharmaceuticals Company, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work has focused on creating innovative solutions for complex health challenges.
Collaborations
Throughout his career, Markwalder has collaborated with talented professionals, including Mona Patel and Anthony J Cocuzza. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jay Andrew Markwalder's contributions to HIV research and pharmaceutical innovation highlight his role as a key inventor in the field. His work continues to impact the development of effective treatments for viral infections.